phenyl 3-(5-(2-((4-morpholin-4-ylphenyl)amino)pyrimidin-4-yl)imidazo[2,1-b][1,3]thiazol-6-yl)phenylcarbamate | 1159884-22-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: phenyl 3-(5-(2-((4-morpholin-4-ylphenyl)amino)pyrimidin-4-yl)imidazo[2,1-b][1,3]thiazol-6-yl)phenylcarbamate
• 英文别名: Phenyl 3-(5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)imidazo[2,1-b]thiazol-6-yl)phenylcarbamate；phenyl N-[3-[5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]carbamate
• CAS: 1159884-22-6
• 化学式: C₃₂H₂₇N₇O₃S
• 分子量: 589.677
• InChiKey: VRTJYLZXQJQCPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  43
• 可旋转键数：
  8
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  134
• 氢给体数：
  2
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  4-(6-(3-aminophenyl)imidazo[2,1-b]thiazol-5-yl)-N-(4-morpholinophenyl)pyrimidin-2-amine 、 氯甲酸苯酯 以 N-甲基吡咯烷酮 为溶剂， 生成 phenyl 3-(5-(2-((4-morpholin-4-ylphenyl)amino)pyrimidin-4-yl)imidazo[2,1-b][1,3]thiazol-6-yl)phenylcarbamate
  参考文献：
  名称：

  Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases

  摘要：

  The design and enzyme activities of a novel class of imidazo[2,1-b]thiazoles is presented. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.03.015

文献信息

• [EN] IMIDAZO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS<br/>[FR] DÉRIVÉS D'IMIDO-THIAZOLE EN TANT QU'INHIBITEURS DE PROTÉINES KINASES
  申请人：ABBOTT LAB

  公开号：WO2009070516A1

  公开（公告）日：2009-06-04

  Compounds of formula I that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula I and therapeutically acceptable salts, prodrugs and salts of prodrugs thereof, wherein X is CH or N; A1 is R1, OR1. NHR1, N(R1)2, NHC(O)R1, NHC(O)NHR1, NHC(O)N(R1)2, NHC(O)OR1, C(O)NHR1, C(O)N(R1)2, C=NOR1, or C(NH2)NOC(O)R1;

  公开了抑制蛋白激酶的化合物I的公式，包含这些化合物的组合物以及使用这些化合物治疗疾病的方法。公式I及其治疗上可接受的盐，前药和前药的盐，其中X为CH或N；A1为R1，OR1，NHR1，N(R1)2，NHC(O)R1，NHC(O)NHR1，NHC(O)N(R1)2，NHC(O)OR1，C(O)NHR1，C(O)N(R1)2，C=NOR1或C(NH2)NOC(O)R1。
• [EN] HISTONE DEACETYLASE INHIBITORS<br/>[FR] INHIBITEURS DE L'HISTONE DÉSACÉTYLASE
  申请人：MERCK & CO INC

  公开号：WO2006017216A1

  公开（公告）日：2006-02-16

  This invention relates to hydroxamic acid derivatives having a urea linkage, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.

  这项发明涉及具有脲键的羟羟基脂肪酸衍生物，这些衍生物是组蛋白去乙酰化酶（HDAC）的抑制剂，可用于预防和/或治疗细胞增殖性疾病，例如癌症、自身免疫、过敏和炎症性疾病，中枢神经系统（CNS）疾病如神经退行性疾病，以及预防和/或治疗再狭窄。
• PROTEIN KINASE INHIBITORS
  申请人：Ba-Maung Nwe Y.

  公开号：US20090253723A1

  公开（公告）日：2009-10-08

  Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.

  本文公开了抑制蛋白激酶的化合物，含有这些化合物的组合物以及使用这些化合物治疗疾病的方法。
• HISTONE DEACETYLASE INHIBITORS
  申请人：Merck & Co., Inc.

  公开号：EP1773761A1

  公开（公告）日：2007-04-18
• IMIDAZO-THIAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS
  申请人：Abbott Laboratories

  公开号：EP2222682A1

  公开（公告）日：2010-09-01